GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAssets Inc (NAS:MDAS) » Definitions » Preferred Stock

MedAssets (MedAssets) Preferred Stock : $0.0 Mil (As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is MedAssets Preferred Stock?

Preferred stock is a special equity security that has properties of both equity and debt. MedAssets's preferred stock for the quarter that ended in Sep. 2015 was $0.0 Mil.

The market value of preferred stock needs to be added to the market value of common stocks in the calculation of Enterprise Value. MedAssets's Enterprise Value for the quarter that ended in Sep. 2015 was $1,986.2 Mil.

In the calculation of book value, the par value of preferred stocks needs to subtracted from total equity. MedAssets's Book Value per Share for the quarter that ended in Sep. 2015 was $7.47.

Dividends paid to preferred stocks need to be subtracted from net income in the calculation of Earnings per Share (Diluted). MedAssets's Earnings per Share (Diluted) for the three months ended in Sep. 2015 was $-0.04.


MedAssets Preferred Stock Historical Data

The historical data trend for MedAssets's Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAssets Preferred Stock Chart

MedAssets Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MedAssets Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MedAssets Preferred Stock Calculation

Preferred Stock is a special equity security that has properties of both equity and debt. It is generally considered a hybrid instrument. Preferred stock is senior to common stock, but is subordinate to bonds in terms of claim or rights to their share of the assets of the company.

Preferred stock has priority over common stock in the payment of dividends and any payments received when a company liquidates.

Preferred stock comes in many forms. It can be:


Convertible or Non-Convertible
Cumulative or Non-Cumulative
Voting or Non-Voting
Callable or Non-Callable
Maturity Date or No Maturity Date

A preferred stock without a maturity date is called a perpetual preferred stock. These are relatively rare. A good example of perpetual preferred stock is the many series of Public Storage (PSA) preferred shares that trade on the New York Stock Exchange.

Before investing in preferred stock, it is important to know which of the above groups the stock belongs to. Is it convertible or non-convertible? Are dividends cumulative or non-cumulative?

It is also critical that an investor knows what bonds the company has in front of the preferred stock. Bondholders get paid first. So the decision to buy a preferred stock can be similar to the decision to buy a bond. But, remember, the preferred stock of a company with bonds is junior to those bonds.

Unless a preferred stock is convertible, the upside in a preferred stock investment is more limited than in a common stock investment. If a company doubles its earnings, it is usually under no more obligation to double the dividends paid to preferred shareholders than it is to double the interest paid to its bankers and bondholders.So preferred stock is very different from common stock.


MedAssets  (NAS:MDAS) Preferred Stock Explanation

When a company needs capital but does not wish to issue debt, they may sell preferred stocks to investors.

For instance, during the financial crisis of 2008, Goldman Sachs (GS) issued a combination of preferred stock and common stock options for $5 billion of capital to Warren Buffett’s Berkshire Hathaway (BRK.A)(BRK.B). In this deal, Berkshire Hathaway paid $5 billion for 10% cumulative perpetual preferred stock and warrants to buy 43.5 million shares of Goldman Sachs at $115 a share. Goldman Sachs bought back the preferred in 2010. Guess how much money Warren Buffett made in this deal in two years? Read How Much Did Warren Buffett’s Berkshire Hathaway (BRK.B) Make on Its Goldman Sachs (GS) Preferred Stock?

1. The market value of Preferred Stocks needs to be added to the market value of common stocks in the calculation of enterprise value.

MedAssets's Enterprise Value for the quarter that ended in Sep. 2015 is calculated as

2. In the calculation of Book Value, the par value of Preferred Stocks needs to subtracted from total equity.

MedAssets's Book Value per Share for the quarter that ended in Sep. 2015 is calculated as

3. Dividends paid to Preferred Stocks need to be subtracted from net income in the calculation of earnings per share.

MedAssets's Earnings per Share (Diluted) (EPS) for the three months ended in Sep. 2015 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedAssets Preferred Stock Related Terms

Thank you for viewing the detailed overview of MedAssets's Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


MedAssets (MedAssets) Business Description

Traded in Other Exchanges
N/A
Address
MedAssets Inc was incorporated in 1999. It is a financial and performance improvement company providing technology-enabled products and services that, together, help mitigate the increasing financial challenges faced by hospitals, health systems, and other non-acute healthcare providers. Its solutions are designed to reduce the total cost of care delivery, enhance operational efficiency, align clinical delivery of physicians and staff to advance care coordination, and improve revenue performance mainly for hospitals and health systems. The Company's solutions integrate with its clients' existing operations and enterprise software systems, and require minimal upfront costs or capital expenditures for its clients. Its technology-enabled solutions are delivered through company-hosted software, sometimes referred to as software as a service or Web-based applications, supported by implementation, process improvement consulting and outsourced services, as well as enterprise-wide sales and client management support. The Company manages its business through two business segments, Spend and Clinical Resource Management (CM) and Revenue Cycle Management (RCM). Within the SCM segment it provides a comprehensive suite of cost management services, supply chain analytics and data capabilities that help its clients reduce their total cost of care delivery, enhance their operational efficiency and align their clinicians' delivery of care with advance care coordination. Its solutions lower operating costs through compliance to its strategic sourcing of supplies and purchased services at discounted prices, supply chain outsourcing and procurement services capabilities. It also help to improve care processes and reduce care variations through the use of its clinical and process improvement consulting services, workforce optimization solutions and business analytics and intelligence tools. The Company's RCM segment is a provider of revenue cycle management solutions to healthcare providers, mainly hospitals and health systems. It provides SaaS or Web-based software and technology-enabled services designed to improve revenue performance for healthcare organizations through patient access and financial responsibility, clinical documentation, charge capture and revenue integrity, pricing analysis, claims processing and denials management, payor contract management, extended business office revenue recovery, accounts receivable services and outsourcing. As of December 31, 2013, the Company's client base included more than 4,400 acute care hospitals and approximately 122,000 ancillary or non-acute provider locations. The Company competes with Allscripts Corporation, Epic Systems Corporation, McKesson Corporation, Siemens AG; Accenture Ltd., Accretive Health, Inc., Deloitte & Touche LLP, Ernst & Young LLP, Craneware Inc., Emdeon Inc. and among others. The Company is subject to federal and state laws and regulations designed to protect patients, government
Executives
Anthony Jr Colaluca officer: Chief Financial Officer MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
Bharat Sundaram officer: President, SCM Segment 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
C A Piccolo director 199 BENSON RD, MIDDLEBURY CT 06749
Carol J Zierhoffer director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Kevin M Twomey director 1650 PRUDENTIAL DR, STE 400, JACKSONVILLE FL 32207
Bruce F Wesson director 1827 PACIFIC ST BROOKLYN NY 11233
R Halsey Wise director, officer: Chairman and CEO 135 PONTE VEDRA BLVD, PONTE VEDRA BEACH FL 32082
Samuel K Skinner director 233 NORTH MICHIGAN AVENUE, 22ND FLOOR, CHICAGO IL 60601
Loucks Vernon R Jr director 1101 SKOKIE BLVD., SUITE 240, NORTHBROOK IL 60062
Laurence Neil Hunn officer: President, Revenue Cycle Tech 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Patrick T Ryan director, officer: President, SCM Segment 401 EDGEWATER PLACE, SUITE 500, WAKEFIELD MA 01880
Claudius Llc 10 percent owner C/O GALEN ASSOCIATES 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020
Galen Partners Iii L P 10 percent owner 610 FIFTH AVE 5TH FL NEW YORK NY 10020
Galen Partners International Iii L P 10 percent owner 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020
Galen Employee Fund Iii Lp 10 percent owner 610 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10020

MedAssets (MedAssets) Headlines

From GuruFocus

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 6,000 Shares

By GuruFocus Research GuruFocus Editor 04-06-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 26,776 Shares

By GuruFocus Research GuruFocus Editor 03-01-2010

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 01-05-2011

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 02-09-2011

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 6,000 Shares

By GuruFocus Research GuruFocus Editor 03-09-2010

MEDASSETS, INC. (MDAS) CFO Laurence Neil Hunn sells 3,100 Shares

By GuruFocus Research GuruFocus Editor 07-08-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 54,000 Shares

By GuruFocus Research GuruFocus Editor 03-01-2010

MEDASSETS, INC. (MDAS) Chairman, President and CEO John A Bardis sells 40,000 Shares

By GuruFocus Research GuruFocus Editor 09-03-2010

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 4,300 Shares

By GuruFocus Research GuruFocus Editor 07-08-2010

MEDASSETS, INC. (MDAS) COO Rand A Ballard sells 15,000 Shares

By GuruFocus Research GuruFocus Editor 12-08-2010